Search results for "Manic-depressive illness"

showing 10 items of 12 documents

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory

2016

BackgroundFunctional remediation is a novel intervention with demonstrated efficacy at improving functional outcome in euthymic bipolar patients. However, in a previous trial no significant changes in neurocognitive measures were detected. The objective of the present analysis was to test the efficacy of this therapy in the enhancement of neuropsychological functions in a subgroup of neurocognitively impaired bipolar patients.MethodA total of 188 out of 239 DSM-IV euthymic bipolar patients performing below two standard deviations from the mean of normative data in any neurocognitive test were included in this subanalysis. Repeated-measures analyses of variance were conducted to assess the i…

AdultMalemedicine.medical_specialtyBipolar DisorderCognition disordersmedicine.medical_treatmenteducation.educational_degreePsychiatric rehabilitationRehabilitació de drogoaddictesNeuropsychological TestsPsychiatric RehabilitationAudiologyVerbal learningTrastorns de la cognició03 medical and health sciences0302 clinical medicinePatient Education as TopicMemorymedicinePsychoeducationHumansManic-depressive illnessBipolar disordereducationApplied PsychologyTrastorn bipolarNeuropsychologyMiddle AgedVerbal Learningmedicine.disease030227 psychiatryPsychiatry and Mental healthNarcotics addicts rehabilitationSchizophreniaMental RecallFemaleVerbal memoryCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryClinical psychology
researchProduct

Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder

2009

Abstract Background The relevance of persistent cognitive deficits to the pathogenesis and prognosis of bipolar disorders (BD) is understudied, and its translation into clinical practice has been limited by the absence of brief methods assessing cognitive status in Psychiatry. This investigation assessed the psychometric properties of the Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) for the detection of cognitive impairment in BD. Methods After short training, psychiatrists at 40 outpatient clinics administered the SCIP three times over two weeks to a total of 76 consecutive type I BD admissions. Experienced psychologists also administered a comprehensive ba…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricsAdolescentPsychometricslcsh:Computer applications to medicine. Medical informaticsAmbulatory Care FacilitiesSensitivity and SpecificityYoung AdultCognitionQuality of lifemedicineManic-depressive illnessOutpatient clinicHumansBipolar disorderPsychiatryTrastorn bipolarResearchNeuropsychologyPublic Health Environmental and Occupational HealthConstruct validityReproducibility of ResultsCognitionGeneral MedicineMiddle Agedmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersLogistic ModelsROC CurveSpainCase-Control StudiesCogniciólcsh:R858-859.7FemalePsicometriaPsychologyCognition DisordersNeurocognitiveClinical psychologyHealth and Quality of Life Outcomes
researchProduct

Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cogn…

2011

Cognitive impairment in schizophrenia and psychosis is ubiquitous and acknowledged as a core feature of clinical expression, pathophysiology, and prediction of functioning. However, assessment of cognitive functioning is excessively time-consuming in routine practice, and brief cognitive instruments specific to psychosis would be of value. Two screening tools have recently been created to address this issue, i.e., the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP). The aim of this research was to examine the comparative validity of these two brief instruments in relation to a global cognitive score. 161 patients with p…

AdultMalemedicine.medical_specialtyPsychosisBipolar DisorderPsychometricsConcurrent validityNeuropsychological TestsPsychological researchSeverity of Illness IndexExecutive FunctionMemorymedicineHumansManic-depressive illnessAttentionBipolar disorderNeuropsychological assessmentPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesTrastorn bipolarmedicine.diagnostic_testReproducibility of ResultsCognitionMiddle Agedmedicine.diseaseCognitivismePsychiatry and Mental healthROC CurveSchizophreniaCognitive remediation therapyArea Under CurveInvestigació psicològicaSchizophreniaFemaleSchizophrenic PsychologyEsquizofrèniaCognition DisordersPsychologyCognitivismClinical psychologyBrief Cognitive Assessment Tool
researchProduct

Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placeb…

2016

Evidence supporting the use of second generation antipsychotics (SGAs) in the treatment of acute depression with mixed features (MFs) associated with bipolar disorder (BD) is scarce and equivocal. Therefore, we conducted a systematic review and preliminary meta-analysis investigating SGAs in the treatment of acute BD depression with MFs. Two authors independently searched major electronic databases from 1990 until September 2015 for randomized (placebo-) controlled trials (RCTs) or open-label clinical trials investigating the efficacy of SGAs in the treatment of acute bipolar depression with MFs. A random-effect meta-analysis calculating the standardized mean difference (SMD) between SGA an…

Bipolar DisorderManic-depressive illness--Treatmentmeta-analysilcsh:ChemistryClinical trials0302 clinical medicineManic-depressive illnessAsenapineAntipsychotic drugslcsh:QH301-705.5Spectroscopydiagnostic and statistical manual for mental disorders fifth edition (DSM-5)PsychiatryDepressionBrief ReportGeneral MedicineComputer Science ApplicationsTreatment OutcomeMeta-analysismixed featureHumanmedicine.drugAntipsychotic Agentsmedicine.medical_specialtyAcute bipolar depression; Diagnostic and statistical manual for mental disorders fifth edition (DSM-5); Meta-analysis; Mixed features; Second generation antipsychotic (SGA); Systematic-review; Physical and Theoretical Chemistry; Organic Chemistry; Spectroscopy; Inorganic Chemistry; Catalysis; Molecular BiologyYoung Mania Rating ScalePlaceboCatalysisInorganic Chemistry03 medical and health sciencessystematic-reviewInternal medicinemedicineHumansZiprasidoneBipolar disorderPhysical and Theoretical ChemistryPsychiatryMolecular BiologyLurasidonemixed featuresbusiness.industryOrganic Chemistrysecond generation antipsychotic (SGA)acute bipolar depressionmedicine.disease030227 psychiatrymeta-analysisAntipsychotic Agentlcsh:Biology (General)lcsh:QD1-999QuetiapineControlled Clinical Trials as Topicbusiness030217 neurology & neurosurgeryInternational Journal of Molecular Sciences
researchProduct

Motor speed predicts stability of cognitive deficits in both schizophrenic and bipolar I patients at one-year follow-up

2009

Background: We examined whether motor speed assessed by the finger tapping test predicts generalized and specific stable deficits because of a common pathogenic process in bipolar and schizophrenic patients. Methods: One hundred and two patients underwent a battery of neuropsychological tests. Patients with a score of less than one standard deviation from their siblings', sample in two assessments with an interval of one year were defined as suffering from stable deficits because of a common pathogenic process. In addition to univariate analyses, factor analyses, ordinal logistic regression, and multiple linear regressions were used. A general score was also calculated. Results: No differen…

Bipolar IEndophenotypeTrastorn bipolarPsicobiologiaCognitive deficitEstudi de casosMotor speedSchizophreniaManic-depressive illnessEsquizofrèniaCase studiesPsychobiologyPsychomotor slowness
researchProduct

Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates

2015

Bipolar disorder (BD) and alcohol use disorders (AUDs) are usually comorbid, and both have been associated with significant neurocognitive impairment. Patients with the BD-AUD comorbidity (dual diagnosis) may have more severe neurocognitive deficits than those with a single diagnosis, but there is paucity of research in this area. To explore this hypothesis more thoroughly, we carried out a systematic literature review through January 2015. Eight studies have examined the effect of AUDs on the neurocognitive functioning of BD patients. Most studies found that BD patients with current or past history of comorbid AUDs show more severe impairments, especially in verbal memory and executive cog…

PHYSIOLOGY (MEDICAL)medicine.medical_specialtyStagingPhysiologyBipolar disorderneurocognitionAddictionReviewAlcohol use disorderComorbiditylcsh:PhysiologyAlcohol use disordersComorbiditatalcohol use disordersPhysiology (medical)mental disordersmedicineManic-depressive illnessBipolar disorderPsychiatryPHYSIOLOGYNeurocognitionbipolar disorderTrastorn bipolarlcsh:QP1-981business.industryCognitionsystems biologystagingmedicine.diseaseComorbidityAlcoholismcomorbiditySystems Biology.Systematic reviewAlcoholismeDual diagnosisaddictionVerbal memorybusinessSystems biologyNeurocognitive
researchProduct

Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals

2019

Fronto-limbic white matter (WM) abnormalities are assumed to lie at the heart of the pathophysiology of bipolar disorder (BD);\ud however, diffusion tensor imaging (DTI) studies have reported heterogeneous results and it is not clear how the clinical\ud heterogeneity is related to the observed differences. This study aimed to identify WM abnormalities that differentiate patients with\ud BD from healthy controls (HC) in the largest DTI dataset of patients with BD to date, collected via the ENIGMA network. We gathered\ud individual tensor-derived regional metrics from 26 cohorts leading to a sample size of N = 3033 (1482 BD and 1551 HC). Mean\ud fractional anisotropy (FA) from 43 regions of i…

Pathologymedicine.medical_specialtyCorpus callosumArticleWhite matter03 medical and health sciences0302 clinical medicineFractional anisotropyCingulum (brain)MedicineManic-depressive illnessBipolar disorderPharmacologyTrastorn bipolarbusiness.industryDiagnostic markersAnisotropiaTranslational researchmedicine.disease030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structureMeta-analysisAnisotropybusiness030217 neurology & neurosurgeryDiffusion MRITractography
researchProduct

1st International Experts' Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00054/full En este artículo científico participan los siguientes autores: Mario Amore, Guido Di Sciascio, Radu Ioan Florea, Marina Garriga, Gabriel Gonzalez, Kai G. Kahl, Per-Axel Karlsson, Jens Kuhn, Maria Margariti, Bruno Pacciardi, Konstantinos Papageorgiou, Maurizio Pompili, Fabrice Rivollier, Ángel Royuela, Gemma Safont, Joachim Scharfetter, Bo Skagen, Kazuhiro Tajima-Pozo y Pierre Vidailhet. Agitation is a heterogeneous concept without a uniformly accepted definition, however, it is generally considered as a state of cognitive and motor hype…

Schizophrenia - Treatment.Psychomotor agitationlcsh:RC435-571media_common.quotation_subjectPsychomotor disorders - Treatment.ReviewMotor HyperactivityPsicosis maníaco depresiva - Tratamiento.Esquizofrenia - Farmacoterapia.Psicomotricidad - Trastornos - Tratamiento.03 medical and health sciences0302 clinical medicinePromotion (rank)Bipolar disorder Clinical practice Management Psychomotor agitation Schizophrenia Psychiatry and Mental HealthNursinglcsh:Psychiatrymedicinebipolar disorder; clinical practice; management; psychomotor agitation; schizophreniaManic-depressive illness030212 general & internal medicineManic-Depressive illness - Treatment.media_commonPsychiatrybipolar disorderProtocol (science)Psicosis maníaco depresiva - Farmacoterapia.Trastorn bipolarHealth professionalsCognitionManic-Depressive illnes - Chemotherapy.clinical practice030227 psychiatryschizophreniaClinical PracticeSchizophrenia - Chemotherapy.Psychiatry and Mental healthpsychomotor agitationSchizophreniaEsquizofrèniaEsquizofrenia - Tratamiento.medicine.symptomEmotional arousalPsychologymanagement
researchProduct

The relationship between genetic risk variants with brain structure and function in bipolar disorder: A systematic review of genetic-neuroimaging stu…

2017

Genetic-neuroimaging paradigms could provide insights regarding the pathophysiology of bipolar disorder (BD). Nevertheless, findings have been inconsistent across studies. A systematic review of gene-imaging studies involving individuals with BD was conducted across electronic major databases from inception until January 9th, 2017. Forty-four studies met eligibility criteria (N = 2122 BD participants). Twenty-six gene variants were investigated across candidate gene studies and 4 studies used a genome-wide association approach. Replicated evidence (i.e. in >2 studies) suggests that individuals with BD carrying the BDNF Val66Met risk allele could have reduced hippocampal volumes compared …

Transtorno BipolarCandidate genediffusion tensor imagingvoxel based morphometryBipolar disorderBipolar disorder Genetic polymorphisms Neuroimaging Magnetic resonance imaging Functional MRI Diffusion tensor imagingvoxel based morphometryCognitive NeuroscienceBrain Structure and FunctionGenome-wide association studyNeuroimagingComputational biologyGenetic polymorphismsFaculty of Social Sciences03 medical and health sciencesDISC1Behavioral Neuroscience0302 clinical medicineMagnetic resonance imagingNeuroimaginggenetic polymorphisms/dk/atira/pure/core/keywords/FacultyOfSocialSciencesImatges per ressonància magnèticamedicineHumansManic-depressive illnessANK3Bipolar disorderCervellNeuroimagemDiffusion tensor imagingvoxel based morphometryFunctional MRIGenetic polymorphismneuroimagingTrastorn bipolarbiologyBipolar disorder; Diffusion tensor imagingvoxel based morphometry; Functional MRI; Genetic polymorphisms; Magnetic resonance imaging; Neuroimaging; Neuropsychology and Physiological Psychology; Cognitive Neuroscience; Behavioral NeuroscienceReproducibility of ResultsBrainmedicine.disease030227 psychiatryNeuropsychology and Physiological Psychology5-HTTLPRbiology.proteinfunctional MRIImagem por Ressonância MagnéticaPsychologyNeuroscience030217 neurology & neurosurgeryHumanGenome-Wide Association Study
researchProduct

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysi…

2010

In recent years, combinations of pharmacological treatments have become common for the treatment of bipolar disorder type I (BP I); however, this practice is usually not evidence-based and rarely considers monotherapy drug regimen (MDR) as an option in the treatment of acute phases of BP I. Therefore, we evaluated comparative data of commonly prescribed MDRs for both manic and depressive phases of BP I. Medline, PsycINFO, EMBASE, the Cochrane Library, the ClinicalStudyResults.org and other data sources were searched from 1949 to March 2009 for placebo and active controlled randomized clinical trials (RCTs). Risk ratios (RRs) for response, remission, and discontinuation rates due to adverse …

medicine.medical_specialtyBipolar I disorderBipolar DisorderDatabases FactualPharmacologyLithiumArticlelaw.inventionTreatment of bipolar disorderRandomized controlled triallawInternal medicinemental disordersmedicineAnimalsHumansManic-depressive illnessPharmacology (medical)Bipolar disorderAntipsychotic drugsRandomized Controlled Trials as TopicPharmacologyTrastorn bipolarbusiness.industrymedicine.diseaseLitiAntidepressive AgentsDiscontinuationPsychiatry and Mental healthAcute DiseaseNumber needed to treatAnticonvulsiusQuetiapineDrug EvaluationAntipsicòticsAnticonvulsantsmedicine.symptombusinessManiamedicine.drug
researchProduct